| 1 | In-Depth Glycoproteomic Assay of Urinary Prostatic Acid Phosphatase | 8.6 | 6 | Citations (PDF) |
| 2 | N-linked Fc glycosylation is not required for IgG-B-cell receptor function in a GC-derived B-cell line | 13.9 | 7 | Citations (PDF) |
| 3 | GlYcoLISA: antigen-specific and subclass-specific IgG Fc glycosylation analysis based on an immunosorbent assay with an LC–MS readout | 14.5 | 18 | Citations (PDF) |
| 4 | Pancreatic cancer-associated fibroblasts modulate macrophage differentiation via sialic acid-Siglec interactions | 4.4 | 48 | Citations (PDF) |
| 5 | (Sialyl)Lewis Antigen Expression on Glycosphingolipids, N-, and O-Glycans in Colorectal Cancer Cell Lines is Linked to a Colon-Like Differentiation Program | 3.0 | 11 | Citations (PDF) |
| 6 | Non‐prime‐ and prime‐side profiling of <scp>P</scp>ro‐<scp>P</scp>ro endopeptidase specificity using synthetic combinatorial peptide libraries and mass spectrometry | 5.5 | 1 | Citations (PDF) |
| 7 | Limited impact of cancer-derived gangliosides on anti-tumor immunity in colorectal cancer | 2.2 | 7 | Citations (PDF) |
| 8 | Comprehensive <i>O</i>-Glycan Analysis by Porous Graphitized Carbon Nanoliquid Chromatography–Mass Spectrometry | 6.5 | 9 | Citations (PDF) |
| 9 | Apolipoprotein-CIII O-Glycosylation Is Associated with Micro- and Macrovascular Complications of Type 2 Diabetes | 4.5 | 8 | Citations (PDF) |
| 10 | Autoimmune hepatitis displays distinctively high multi-antennary sialylation on plasma N-glycans compared to other liver diseases | 6.6 | 5 | Citations (PDF) |
| 11 | Neutrophil Depletion Changes the N-Glycosylation Pattern of IgG in Experimental Murine Sepsis | 4.5 | 5 | Citations (PDF) |
| 12 | Anion Exchange Chromatography–Mass Spectrometry to Characterize Proteoforms of Alpha-1-Acid Glycoprotein during and after Pregnancy | 3.5 | 3 | Citations (PDF) |
| 13 | Influence of AAV vector tropism on long-term expression and Fc-γ receptor binding of an antibody targeting SARS-CoV-2 | 4.4 | 1 | Citations (PDF) |
| 14 | Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing | 4.4 | 13 | Citations (PDF) |
| 15 | A roadmap to the molecular human linking multiomics with population traits and diabetes subtypes | 13.9 | 22 | Citations (PDF) |
| 16 | Direct glycosylation analysis of intact monoclonal antibodies combining ESI MS of glycoforms and MALDI-in source decay MS of glycan fragments | 5.6 | 8 | Citations (PDF) |
| 17 | Phagocytosis of platelets opsonized with differently glycosylated anti-HLA hIgG1 by monocyte-derived macrophages | 2.5 | 3 | Citations (PDF) |
| 18 | <scp>ST3GAL5</scp>‐catalyzed gangliosides inhibit <scp>TGF</scp>‐β‐induced epithelial‐mesenchymal transition via <scp>TβRI</scp> degradation | 7.4 | 34 | Citations (PDF) |
| 19 | IgG Fab Glycans Hinder FcRn-Mediated Placental Transport | 0.6 | 18 | Citations (PDF) |
| 20 | O-Glycomic and Proteomic Signatures of Spontaneous and Butyrate-Stimulated Colorectal Cancer Cell Line Differentiation | 3.0 | 7 | Citations (PDF) |
| 21 | Transcriptionally imprinted glycomic signatures of acute myeloid leukemia | 5.6 | 10 | Citations (PDF) |
| 22 | Online Collision-Induced Unfolding of Therapeutic Monoclonal Antibody Glyco-Variants through Direct Hyphenation of Cation Exchange Chromatography with Native Ion Mobility–Mass Spectrometry | 6.5 | 15 | Citations (PDF) |
| 23 | Analysis of Immunogenic Galactose-α-1,3-galactose-Containing <i>N</i>-Glycans in Beef, Mutton, and Pork Tenderloin by Combining Matrix-Assisted Laser Desorption/Ionization-Mass Spectroscopy and Capillary Electrophoresis Hyphenated with Mass Spectrometry via Electrospray Ionization | 6.0 | 8 | Citations (PDF) |
| 24 | In-Depth Analysis of the N-Glycome of Colorectal Cancer Cell Lines | 4.5 | 10 | Citations (PDF) |
| 25 | N-Glycosylation of LRP6 by B3GnT2 Promotes Wnt/β-Catenin Signalling | 4.8 | 7 | Citations (PDF) |
| 26 | Neutron-encoded diubiquitins to profile linkage selectivity of deubiquitinating enzymes | 13.9 | 14 | Citations (PDF) |
| 27 | Human Prostate-Specific Antigen Carries N-Glycans with Ketodeoxynononic Acid | 7.9 | 6 | Citations (PDF) |
| 28 | Serum N-Glycosylation RPLC-FD-MS Assay to Assess Colorectal Cancer Surgical Interventions | 4.4 | 4 | Citations (PDF) |
| 29 | ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19 | 24.2 | 31 | Citations (PDF) |
| 30 | An Integrated Glycosylation Signature of Rheumatoid Arthritis | 4.4 | 13 | Citations (PDF) |
| 31 | Immunoglobulin A Glycosylation Differs between Crohn’s Disease and Ulcerative Colitis | 3.5 | 12 | Citations (PDF) |
| 32 | Apolipoprotein-CIII O-Glycosylation, a Link between GALNT2 and Plasma Lipids | 4.5 | 6 | Citations (PDF) |
| 33 | High sensitivity glycomics in biomedicine | 6.9 | 22 | Citations (PDF) |
| 34 | Lipopolysaccharide O-antigen molecular and supramolecular modifications of plant root microbiota are pivotal for host recognition | 12.2 | 21 | Citations (PDF) |
| 35 | Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits | 4.4 | 32 | Citations (PDF) |
| 36 | Antibody glycosylation in COVID-19 | 2.8 | 22 | Citations (PDF) |
| 37 | Prevention of Fetal/Neonatal Alloimmune Thrombocytopenia in Mice: Biochemical and Cell Biological Characterization of Isoforms of a Human Monoclonal Antibody | 1.7 | 5 | Citations (PDF) |
| 38 | Detailed Analytical Characterization of a Bispecific IgG1 CrossMab Antibody of the Knob-into-Hole Format Applying Various Stress Conditions Revealed Pronounced Stability | 4.3 | 13 | Citations (PDF) |
| 39 | Studying protein structure and function by native separation–mass spectrometry | 46.7 | 55 | Citations (PDF) |
| 40 | Native Liquid Chromatography and Mass Spectrometry to Structurally and Functionally Characterize Endo-Xylanase Proteoforms | 4.5 | 9 | Citations (PDF) |
| 41 | Differential <i>N</i>‐ and <i>O</i>‐glycosylation signatures of HIV‐1 Gag virus‐like particles and coproduced extracellular vesicles | 3.9 | 11 | Citations (PDF) |
| 42 | Transforming growth factor-β challenge alters the N-, O-, and glycosphingolipid glycomes in PaTu-S pancreatic adenocarcinoma cells | 2.2 | 8 | Citations (PDF) |
| 43 | IgG Anti–Citrullinated Protein Antibody Variable Domain Glycosylation Increases Before the Onset of Rheumatoid Arthritis and Stabilizes Thereafter: A Cross‐Sectional Study Encompassing ~1,500 Samples | 7.4 | 45 | Citations (PDF) |
| 44 | Glycosphingolipid-Glycan Signatures of Acute Myeloid Leukemia Cell Lines Reflect Hematopoietic Differentiation | 3.5 | 14 | Citations (PDF) |
| 45 | Fc galactosylation of anti-platelet human IgG1 alloantibodies enhances complement activation on platelets | 4.1 | 30 | Citations (PDF) |
| 46 | Glycan and Protein Analysis of Glycoengineered Bacterial <i>E. coli</i> Vaccines by MALDI-in-Source Decay FT-ICR Mass Spectrometry | 6.5 | 17 | Citations (PDF) |
| 47 | High-Mannose N-Glycans as Malignant Progression Markers in Early-Stage Colorectal Cancer | 4.0 | 55 | Citations (PDF) |
| 48 | Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19 | 9.9 | 57 | Citations (PDF) |
| 49 | Developments and perspectives in high-throughput protein glycomics: enabling the analysis of thousands of samples | 2.2 | 44 | Citations (PDF) |
| 50 | Surface Ig variable domain glycosylation affects autoantigen binding and acts as threshold for human autoreactive B cell activation | 11.0 | 66 | Citations (PDF) |
| 51 | Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood | 4.5 | 18 | Citations (PDF) |
| 52 | High Diversity of Glycosphingolipid Glycans of Colorectal Cancer Cell Lines Reflects the Cellular Differentiation Phenotype | 3.0 | 19 | Citations (PDF) |
| 53 | Sialic Acid Derivatization of Fluorescently Labeled <i>N</i>-Glycans Allows Linkage Differentiation by Reversed-Phase Liquid Chromatography–Fluorescence Detection–Mass Spectrometry | 6.5 | 24 | Citations (PDF) |
| 54 | PHGDH heterogeneity potentiates cancer cell dissemination and metastasis | 38.7 | 187 | Citations (PDF) |
| 55 | Immunoassay for quantification of antigen-specific IgG fucosylation | 9.9 | 22 | Citations (PDF) |
| 56 | High-Throughput Glycomic Methods | 52.7 | 83 | Citations (PDF) |
| 57 | Altered Fc glycosylation of anti‐HLA alloantibodies in hemato‐oncological patients receiving platelet transfusions | 3.9 | 11 | Citations (PDF) |
| 58 | Comprehensive Multidimensional Liquid Chromatography–Mass Spectrometry for the Characterization of Charge Variants of a Bispecific Antibody | 2.6 | 15 | Citations (PDF) |
| 59 | Glycobiology of rheumatic diseases | 27.8 | 79 | Citations (PDF) |
| 60 | IgG Fc N-Glycosylation Translates MHCII Haplotype into Autoimmune Skin Disease | 2.3 | 16 | Citations (PDF) |
| 61 | N-Glycomic Signature of Stage II Colorectal Cancer and Its Association With the Tumor Microenvironment | 3.0 | 59 | Citations (PDF) |
| 62 | Anion exchange chromatography – Mass spectrometry for monitoring multiple quality attributes of erythropoietin biopharmaceuticals | 5.8 | 26 | Citations (PDF) |
| 63 | The SPPL3-Defined Glycosphingolipid Repertoire Orchestrates HLA Class I-Mediated Immune Responses | 23.3 | 97 | Citations (PDF) |
| 64 | Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity | 36.4 | 352 | Citations (PDF) |
| 65 | Sheathless CE‐MS as a tool for monitoring exchange efficiency and stability of bispecific antibodies | 2.6 | 12 | Citations (PDF) |
| 66 | High-throughput glycopeptide profiling of prostate-specific antigen from seminal plasma by MALDI-MS | 5.9 | 18 | Citations (PDF) |
| 67 | Sugar Matters: Improving In Vivo Clearance Rate of Highly Glycosylated Recombinant Plasma Proteins for Therapeutic Use | 4.4 | 3 | Citations (PDF) |
| 68 | The structure and role of lactone intermediates in linkage-specific sialic acid derivatization reactions | 2.8 | 11 | Citations (PDF) |
| 69 | Human Gb3/CD77 synthase produces P1 glycotope-capped N-glycans, which mediate Shiga toxin 1 but not Shiga toxin 2 cell entry | 2.2 | 23 | Citations (PDF) |
| 70 | Site-Specific <i>N</i>-Linked Glycosylation Analysis of Human Carcinoembryonic Antigen by Sheathless Capillary Electrophoresis–Tandem Mass Spectrometry | 3.5 | 44 | Citations (PDF) |
| 71 | Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer | 4.5 | 22 | Citations (PDF) |
| 72 | Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1–associated membranous nephropathy | 10.7 | 154 | Citations (PDF) |
| 73 | Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis | 7.6 | 43 | Citations (PDF) |
| 74 | Analysis of Synthetic Monodisperse Polysaccharides by Wide Mass Range Ultrahigh-Resolution MALDI Mass Spectrometry | 6.5 | 29 | Citations (PDF) |
| 75 | Serum N-glycan profiles differ for various breast cancer subtypes | 2.8 | 24 | Citations (PDF) |
| 76 | Profiling the proteoforms of urinary prostate-specific antigen by capillary electrophoresis – mass spectrometry | 2.4 | 23 | Citations (PDF) |
| 77 | Serum and Plasma Immunoglobulin G Fc N-Glycosylation Is Stable during Storage | 3.5 | 12 | Citations (PDF) |
| 78 | Terminal α2,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells | 4.2 | 45 | Citations (PDF) |
| 79 | Structural and Functional Characterization of SARS-CoV-2 RBD Domains Produced in Mammalian Cells | 6.5 | 53 | Citations (PDF) |
| 80 | Oxonium Ion Guided Analysis of Quantitative Proteomics Data Reveals Site-Specific O-Glycosylation of Anterior Gradient Protein 2 (AGR2) | 4.5 | 15 | Citations (PDF) |
| 81 | ST6Gal1 targets the ectodomain of ErbB2 in a site-specific manner and regulates gastric cancer cell sensitivity to trastuzumab | 6.7 | 54 | Citations (PDF) |
| 82 | Afucosylated IgG Targets FcγRIV for Enhanced Tumor Therapy in Mice | 4.0 | 11 | Citations (PDF) |
| 83 | Large-Scale Analysis of Apolipoprotein CIII Glycosylation by Ultrahigh Resolution Mass Spectrometry | 3.6 | 14 | Citations (PDF) |
| 84 | High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote inflammation by alveolar macrophages | 12.7 | 219 | Citations (PDF) |
| 85 | O- and N-Glycosylation of Serum Immunoglobulin A is Associated with IgA Nephropathy and Glomerular Function | 0.4 | 75 | Citations (PDF) |
| 86 | A semi-automated, high throughput approach for O-glycosylation profiling of in vitro established cancer cell lines by MALDI-FT-ICR MS | 2.8 | 7 | Citations (PDF) |
| 87 | Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for plateletsBlood, 2021, 138, 1481-1489 | 4.2 | 94 | Citations (PDF) |
| 88 | Fc Galactosylation Promotes Hexamerization of Human IgG1, Leading to Enhanced Classical Complement Activation | 0.6 | 84 | Citations (PDF) |
| 89 | Association of Antibody-Dependent Neutrophil Phagocytosis With Distinct Antibody Glycosylation Profiles Following Typhoid Vaccination | 1.8 | 3 | Citations (PDF) |
| 90 | Native Structural and Functional Proteoform Characterization of the Prolyl-Alanyl-Specific Endoprotease EndoPro from <i>Aspergillus niger</i> | 3.5 | 14 | Citations (PDF) |
| 91 | Protein Mannosylation as a Diagnostic and Prognostic Biomarker of Lupus Nephritis: An Unusual Glycan Neoepitope in Systemic Lupus Erythematosus | 7.4 | 31 | Citations (PDF) |
| 92 | Glycoform analysis of intact erythropoietin by MALDI FT-ICR mass spectrometry | 5.8 | 13 | Citations (PDF) |
| 93 | Plasma protein<i>N-</i>glycosylation is associated with cardiovascular disease, nephropathy, and retinopathy in type 2 diabetes | 3.6 | 31 | Citations (PDF) |
| 94 | Biophysical Evaluation of Rhesus Macaque Fc Gamma Receptors Reveals Similar IgG Fc Glycoform Preferences to Human Receptors | 5.1 | 10 | Citations (PDF) |
| 95 | Afucosylated Plasmodium falciparum-specific IgG is induced by infection but not by subunit vaccination | 13.9 | 55 | Citations (PDF) |
| 96 | Integrated N- and O-Glycomics of Acute Myeloid Leukemia (AML) Cell Lines | 4.8 | 21 | Citations (PDF) |
| 97 | Affinity Capillary Electrophoresis–Mass Spectrometry as a Tool to Unravel Proteoform-Specific Antibody–Receptor Interactions | 6.5 | 22 | Citations (PDF) |
| 98 | Glycation Interferes with the Expression of Sialyltransferases in Meningiomas | 4.8 | 12 | Citations (PDF) |
| 99 | A functional spleen contributes to afucosylated IgG in humans | 3.5 | 7 | Citations (PDF) |
| 100 | Monitoring of immunoglobulin N- and O-glycosylation in health and disease | 2.2 | 104 | Citations (PDF) |
| 101 | IgG Fc glycosylation as an axis of humoral immunity in childhood | 6.2 | 39 | Citations (PDF) |
| 102 | Characterization of Macrophage Galactose-type Lectin (MGL) ligands in colorectal cancer cell lines | 2.0 | 35 | Citations (PDF) |
| 103 | IgA subclasses have different effector functions associated with distinct glycosylation profiles | 13.9 | 227 | Citations (PDF) |
| 104 | O- and N-glycosylation analysis of cell lines by ultrahigh resolution MALDI-FTICR-MS | 1.6 | 7 | Citations (PDF) |
| 105 | Intact and subunit-specific analysis of bispecific antibodies by sheathless CE-MS | 5.8 | 33 | Citations (PDF) |
| 106 | MS-Based Allotype-Specific Analysis of Polyclonal IgG-Fc N-Glycosylation | 5.1 | 21 | Citations (PDF) |
| 107 | N-Glycoproteins Have a Major Role in MGL Binding to Colorectal Cancer Cell Lines: Associations with Overall Proteome Diversity | 4.5 | 14 | Citations (PDF) |
| 108 | Prominent members of the human gut microbiota express endo-acting O-glycanases to initiate mucin breakdown | 13.9 | 126 | Citations (PDF) |
| 109 | Mass spectrometry in clinical glycomics: The path from biomarker identification to clinical implementation | 1.9 | 31 | Citations (PDF) |
| 110 | Site-Specific Glycosylation Mapping of Fc Gamma Receptor IIIb from Neutrophils of Individual Healthy Donors | 6.5 | 16 | Citations (PDF) |
| 111 | Immunoglobulin G Glycoprofiles are Unaffected by Common Bottom-Up Sample Processing | 3.5 | 5 | Citations (PDF) |
| 112 | Serum <i>N</i>‐Glycome analysis reveals pancreatic cancer disease signatures | 2.7 | 39 | Citations (PDF) |
| 113 | Biological and structural characterization of murine TRALI antibody reveals increased Fc-mediated complement activation | 5.1 | 14 | Citations (PDF) |
| 114 | Improved N- and C-Terminal Sequencing of Proteins by Combining Positive and Negative Ion MALDI In-Source Decay Mass Spectrometry | 6.5 | 10 | Citations (PDF) |
| 115 | Dissecting Total Plasma and Protein-Specific Glycosylation Profiles in Congenital Disorders of Glycosylation | 4.5 | 23 | Citations (PDF) |
| 116 | Differential O- and Glycosphingolipid Glycosylation in Human Pancreatic Adenocarcinoma Cells With Opposite Morphology and Metastatic Behavior | 2.7 | 24 | Citations (PDF) |
| 117 | Glycomics studies using sialic acid derivatization and mass spectrometry | 46.7 | 116 | Citations (PDF) |
| 118 | Evaluation of Sibling and Twin Fragment Ions Improves the Structural Characterization of Proteins by Top-Down MALDI In-Source Decay Mass Spectrometry | 6.5 | 10 | Citations (PDF) |
| 119 | A Matrix-Assisted Laser Desorption/Ionization—Mass Spectrometry Assay for the Relative Quantitation of Antennary Fucosylated N-Glycans in Human Plasma | 3.6 | 17 | Citations (PDF) |
| 120 | Systematic Evaluation of Normalization Methods for Glycomics Data Based on Performance of Network Inference | 3.5 | 20 | Citations (PDF) |
| 121 | IgG Fc sialylation is regulated during the germinal center reaction following immunization with different adjuvants | 6.2 | 61 | Citations (PDF) |
| 122 | Monoclonal immunoglobulins promote bone loss in multiple myelomaBlood, 2020, 136, 2656-2666 | 4.2 | 30 | Citations (PDF) |
| 123 | Metformin and statin use associate with plasma protein<i>N</i>-glycosylation in people with type 2 diabetes | 3.6 | 14 | Citations (PDF) |
| 124 | Anti-D monoclonal antibodies from 23 human and rodent cell lines display diverse IgG Fc-glycosylation profiles that determine their clinical efficacy | 3.5 | 18 | Citations (PDF) |
| 125 | Simultaneous Immunoglobulin A and G Glycopeptide Profiling for High-Throughput Applications | 6.5 | 44 | Citations (PDF) |
| 126 | IgG-Fc glycosylation before and after rituximab treatment in immune thrombocytopenia | 3.5 | 17 | Citations (PDF) |
| 127 | Natural killer cell activation by respiratory syncytial virus‐specific antibodies is decreased in infants with severe respiratory infections and correlates with Fc‐glycosylation | 3.6 | 35 | Citations (PDF) |
| 128 | Glycosylation of immunoglobulin G is regulated by a large network of genes pleiotropic with inflammatory diseases | 11.0 | 125 | Citations (PDF) |
| 129 | Development of a 96-well plate sample preparation method for integrated<i>N</i>- and<i>O</i>-glycomics using porous graphitized carbon liquid chromatography-mass spectrometry | 2.4 | 64 | Citations (PDF) |
| 130 | Colorectal cancer cell lines show striking diversity of their O-glycome reflecting the cellular differentiation phenotype | 5.6 | 53 | Citations (PDF) |
| 131 | Role of glycosylation in TGF-β signaling and epithelial-to-mesenchymal transition in cancer | 3.6 | 66 | Citations (PDF) |
| 132 | Seizure protein 6 controls glycosylation and trafficking of kainate receptor subunits GluK2 and GluK3 | 7.4 | 29 | Citations (PDF) |
| 133 | FcγR Binding and ADCC Activity of Human IgG Allotypes | 5.1 | 183 | Citations (PDF) |
| 134 | Targeting Glycans and Heavily Glycosylated Proteins for Tumor Imaging | 4.0 | 17 | Citations (PDF) |
| 135 | Semiautomated glycoproteomics data analysis workflow for maximized glycopeptide identification and reliable quantification | 2.0 | 8 | Citations (PDF) |
| 136 | Recombinant human monoclonal HLA antibodies of different IgG subclasses recognising the same epitope: Excellent tools to study differential effects of donor‐specific antibodies | 0.5 | 12 | Citations (PDF) |
| 137 | OGT Controls the Expression and the Glycosylation of E‐cadherin, and Affects Glycosphingolipid Structures in Human Colon Cell Lines | 3.1 | 12 | Citations (PDF) |
| 138 | Human DC-SIGN and CD23 do not interact with human IgG | 3.5 | 51 | Citations (PDF) |
| 139 | Glycoform-resolved FcɣRIIIa affinity chromatography–mass spectrometryMAbs, 2019, 11, 1191-1196 | 10.3 | 53 | Citations (PDF) |
| 140 | Towards a standardized bioinformatics infrastructure for N- and O-glycomics | 13.9 | 93 | Citations (PDF) |
| 141 | The Glycosylation Site of Myelin Oligodendrocyte Glycoprotein Affects Autoantibody Recognition in a Large Proportion of Patients | 5.1 | 18 | Citations (PDF) |
| 142 | Dried blood spot N-glycome analysis by MALDI mass spectrometry | 5.9 | 24 | Citations (PDF) |
| 143 | Expanding the Reaction Space of Linkage-Specific Sialic Acid Derivatization | 4.3 | 23 | Citations (PDF) |
| 144 | <i>N</i>‐glycome signatures in human plasma: associations with physiology and major diseases | 2.7 | 95 | Citations (PDF) |
| 145 | On the presence of HLA-SE alleles and ACPA-IgG variable domain glycosylation in the phase preceding the development of rheumatoid arthritis | 12.4 | 52 | Citations (PDF) |
| 146 | Mo1764 – Serum N-Glycomic Biomarkers Predict Treatment Escalation in Inflammatory Bowel Disease | 1.0 | 0 | Citations (PDF) |
| 147 | <i>N</i>‐Linked Glycans in the Variable Domain of IgG Anti–Citrullinated Protein Antibodies Predict the Development of Rheumatoid Arthritis | 7.4 | 111 | Citations (PDF) |
| 148 | Highly sensitive CE-ESI-MS analysis of N-glycans from complex biological samples | 13.9 | 125 | Citations (PDF) |
| 149 | Serum protein N-glycosylation changes in multiple myeloma | 2.0 | 43 | Citations (PDF) |
| 150 | N-Glycomic and Transcriptomic Changes Associated with CDX1 mRNA Expression in Colorectal Cancer Cell Lines | 4.8 | 23 | Citations (PDF) |
| 151 | The Role of Glycosphingolipids in Immune Cell Functions | 5.1 | 144 | Citations (PDF) |
| 152 | Functional Attributes of Antibodies, Effector Cells, and Target Cells Affecting NK Cell–Mediated Antibody-Dependent Cellular Cytotoxicity | 0.6 | 71 | Citations (PDF) |
| 153 | Proteoform-Resolved FcɤRIIIa Binding Assay for Fab Glycosylated Monoclonal Antibodies Achieved by Affinity Chromatography Mass Spectrometry of Fc Moieties | 3.6 | 22 | Citations (PDF) |
| 154 | Glycoproteomic Analysis of MGL-Binding Proteins on Acute T-Cell Leukemia Cells | 3.5 | 21 | Citations (PDF) |
| 155 | Structural Analysis of Monoclonal Antibodies by Ultrahigh Resolution MALDI In-Source Decay FT-ICR Mass Spectrometry | 6.5 | 57 | Citations (PDF) |
| 156 | Improved and semi-automated reductive β-elimination workflow for higher throughput protein O-glycosylation analysis | 2.4 | 24 | Citations (PDF) |
| 157 | Unique patterns of glycosylation in immunoglobulin subclass G4‐related disease and primary sclerosing cholangitis | 2.7 | 40 | Citations (PDF) |
| 158 | High-throughput Serum N-Glycomics: Method Comparison and Application to Study Rheumatoid Arthritis and Pregnancy-associated Changes | 3.0 | 82 | Citations (PDF) |
| 159 | An In-Depth Glycosylation Assay for Urinary Prostate-Specific Antigen | 6.5 | 64 | Citations (PDF) |
| 160 | The glycomic effect of N-acetylglucosaminyltransferase III overexpression in metastatic melanoma cells. GnT-III modifies highly branched N-glycans | 2.8 | 32 | Citations (PDF) |
| 161 | Low amounts of bisecting glycans characterize cerebrospinal fluid-borne IgG | 2.4 | 5 | Citations (PDF) |
| 162 | Serum sialylation changes in cancer | 2.8 | 157 | Citations (PDF) |
| 163 | Cutis laxa, exocrine pancreatic insufficiency and altered cellular metabolomics as additional symptoms in a new patient with ATP6AP1-CDG | 1.4 | 31 | Citations (PDF) |
| 164 | Adaptive antibody diversification through
<i>N</i>
-linked glycosylation of the immunoglobulin variable region | 7.6 | 128 | Citations (PDF) |
| 165 | Effluent and serum protein N-glycosylation is associated with inflammation and peritoneal membrane transport characteristics in peritoneal dialysis patients | 3.5 | 18 | Citations (PDF) |
| 166 | N- and O-glycosylation Analysis of Human C1-inhibitor Reveals Extensive Mucin-type O-Glycosylation | 3.0 | 59 | Citations (PDF) |
| 167 | Conserved FcγR- glycan discriminates between fucosylated and afucosylated IgG in humans and mice | 2.3 | 35 | Citations (PDF) |
| 168 | Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases | 1.0 | 144 | Citations (PDF) |
| 169 | Sialylation of IgG antibodies inhibits IgG-mediated allergic reactions | 6.2 | 46 | Citations (PDF) |
| 170 | IgG glycosylation and DNA methylation are interconnected with smoking | 2.0 | 38 | Citations (PDF) |
| 171 | α1-Antichymotrypsin Present in Therapeutic C1-Inhibitor Products Competes with Selectin–Sialyl LewisX Interaction | 4.2 | 1 | Citations (PDF) |
| 172 | Automated Plasma Glycomics with Linkage-Specific Sialic Acid Esterification and Ultrahigh Resolution MS | 6.5 | 62 | Citations (PDF) |
| 173 | Comparative Glycomics of Immunoglobulin A and G From Saliva and Plasma Reveals Biomarker Potential | 5.1 | 79 | Citations (PDF) |
| 174 | Restricted immune activation and internalisation of anti-idiotype complexes between drug and antidrug antibodies | 12.4 | 28 | Citations (PDF) |
| 175 | Biophysical analysis of sialic acid recognition by the complement regulator Factor H | 2.2 | 53 | Citations (PDF) |
| 176 | Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel Diseases | 1.0 | 104 | Citations (PDF) |
| 177 | Fc-Glycosylation in Human IgG1 and IgG3 Is Similar for Both Total and Anti-Red-Blood Cell Anti-K Antibodies | 5.1 | 29 | Citations (PDF) |
| 178 | Genome-Wide Association Study on Immunoglobulin G Glycosylation Patterns | 5.1 | 78 | Citations (PDF) |
| 179 | Immunoglobulin G Fragment Crystallizable Glycosylation After Hematopoietic Stem Cell Transplantation Is Dissimilar to Donor Profiles | 5.1 | 8 | Citations (PDF) |
| 180 | Serum Protein N-Glycosylation Changes with Rheumatoid Arthritis Disease Activity during and after Pregnancy | 2.6 | 52 | Citations (PDF) |
| 181 | HappyTools: A software for high-throughput HPLC data processing and quantitation | 2.4 | 37 | Citations (PDF) |
| 182 | Estrogen induces St6gal1 expression and increases IgG sialylation in mice and patients with rheumatoid arthritis: a potential explanation for the increased risk of rheumatoid arthritis in postmenopausal women | 4.2 | 97 | Citations (PDF) |
| 183 | Plasma protein N-glycan signatures of type 2 diabetes | 2.0 | 65 | Citations (PDF) |
| 184 | Differences in IgG Fc Glycosylation Are Associated with Outcome of Pediatric Meningococcal Sepsis | 4.4 | 24 | Citations (PDF) |
| 185 | Serum <i>N</i>-glycome alterations in colorectal cancer associate with survival | 1.7 | 60 | Citations (PDF) |
| 186 | Glycosylation Changes Triggered by the Differentiation of Monocytic THP-1 Cell Line into Macrophages | 3.5 | 42 | Citations (PDF) |
| 187 | Structural Analysis of Variable Domain Glycosylation of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis Reveals the Presence of Highly Sialylated Glycans | 3.0 | 97 | Citations (PDF) |
| 188 | Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis | 9.9 | 95 | Citations (PDF) |
| 189 | Detailed Characterization of Monoclonal Antibody Receptor Interaction Using Affinity Liquid Chromatography Hyphenated to Native Mass Spectrometry | 6.5 | 48 | Citations (PDF) |
| 190 | Identification of sequence variants influencing immunoglobulin levels | 26.1 | 107 | Citations (PDF) |
| 191 | Sialic acid linkage differentiation of glycopeptides using capillary electrophoresis – electrospray ionization – mass spectrometry | 3.5 | 90 | Citations (PDF) |
| 192 | Automated quantification of metabolites in blood-derived samples by NMR | 5.8 | 26 | Citations (PDF) |
| 193 | Enhanced Effector Functions Due to Antibody Defucosylation Depend on the Effector Cell Fcγ Receptor Profile | 0.6 | 83 | Citations (PDF) |
| 194 | Human Plasma N-glycosylation as Analyzed by Matrix-Assisted Laser Desorption/Ionization-Fourier Transform Ion Cyclotron Resonance-MS Associates with Markers of Inflammation and Metabolic Health | 3.0 | 63 | Citations (PDF) |
| 195 | Subclass-specific IgG glycosylation is associated with markers of inflammation and metabolic health | 3.5 | 151 | Citations (PDF) |
| 196 | Patients with IgG1-anti-red blood cell autoantibodies show aberrant Fc-glycosylation | 3.5 | 32 | Citations (PDF) |
| 197 | Affinity purification of erythropoietin from cell culture supernatant combined with MALDI-TOF-MS analysis of erythropoietin N-glycosylation | 3.5 | 27 | Citations (PDF) |
| 198 | Profiling of different pancreatic cancer cells used as models for metastatic behaviour shows large variation in their N-glycosylation | 3.5 | 55 | Citations (PDF) |
| 199 | Network inference from glycoproteomics data reveals new reactions in the IgG glycosylation pathway | 13.9 | 79 | Citations (PDF) |
| 200 | Structural Characterization of Biofunctionalized Gold Nanoparticles by Ultrahigh-Resolution Mass Spectrometry | 15.3 | 52 | Citations (PDF) |
| 201 | The whipworm (<i>Trichuris suis</i>) secretes prostaglandin E2 to suppress proinflammatory properties in human dendritic cells | 0.7 | 59 | Citations (PDF) |
| 202 | Antigen specificity determines anti‐red blood cell IgG‐Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn | 2.4 | 60 | Citations (PDF) |
| 203 | The N-Glycosylation of Mouse Immunoglobulin G (IgG)-Fragment Crystallizable Differs Between IgG Subclasses and Strains | 5.1 | 66 | Citations (PDF) |
| 204 | Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities | 5.1 | 344 | Citations (PDF) |
| 205 | IgA N- and O-glycosylation profiling reveals no association with the pregnancy-related improvement in rheumatoid arthritis | 4.2 | 33 | Citations (PDF) |
| 206 | Maternal and Fetal Mechanisms of B Cell Regulation during Pregnancy: Human Chorionic Gonadotropin Stimulates B Cells to Produce IL-10 While Alpha-Fetoprotein Drives Them into Apoptosis | 5.1 | 80 | Citations (PDF) |
| 207 | Variation of Human Salivary O-Glycome | 2.4 | 20 | Citations (PDF) |
| 208 | Classification for Longevity Potential: The Use of Novel Biomarkers | 2.9 | 10 | Citations (PDF) |
| 209 | Glycosylation pattern of anti‐platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia | 2.4 | 97 | Citations (PDF) |
| 210 | Multimodal Mass Spectrometry Imaging of <i>N</i>-Glycans and Proteins from the Same Tissue Section | 6.5 | 103 | Citations (PDF) |
| 211 | Pregnancy-associated serum N-glycome changes studied by high-throughput MALDI-TOF-MS | 3.5 | 60 | Citations (PDF) |
| 212 | Longitudinal monitoring of immunoglobulin A glycosylation during pregnancy by simultaneous MALDI-FTICR-MS analysis of N- and O-glycopeptides | 3.5 | 43 | Citations (PDF) |
| 213 | IgG1 Fc N-glycan galactosylation as a biomarker for immune activation | 3.5 | 80 | Citations (PDF) |
| 214 | Changes in Healthy Human IgG Fc-Glycosylation after Birth and during Early Childhood | 3.5 | 108 | Citations (PDF) |
| 215 | Linkage-Specific <i>in Situ</i> Sialic Acid Derivatization for N-Glycan Mass Spectrometry Imaging of Formalin-Fixed Paraffin-Embedded Tissues | 6.5 | 177 | Citations (PDF) |
| 216 | N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression | 3.0 | 82 | Citations (PDF) |
| 217 | Dopant Enriched Nitrogen Gas Combined with Sheathless Capillary Electrophoresis–Electrospray Ionization-Mass Spectrometry for Improved Sensitivity and Repeatability in Glycopeptide Analysis | 6.5 | 71 | Citations (PDF) |
| 218 | Applying mini-bore HPAEC-MS/MS for the characterization and quantification of Fc N -glycans from heterogeneously glycosylated IgGs | 2.6 | 39 | Citations (PDF) |
| 219 | Automated High-Throughput Permethylation for Glycosylation Analysis of Biologics Using MALDI-TOF-MS | 6.5 | 78 | Citations (PDF) |
| 220 | Murine Plasma <i>N</i>-Glycosylation Traits Associated with Sex and Strain | 3.5 | 29 | Citations (PDF) |
| 221 | DNA hypomethylation upregulates expression of the MGAT3 gene in HepG2 cells and leads to changes in N-glycosylation of secreted glycoproteins | 3.5 | 30 | Citations (PDF) |
| 222 | Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans | 3.5 | 123 | Citations (PDF) |
| 223 | MALDI-TOF-MS reveals differential N-linked plasma- and IgG-glycosylation profiles between mothers and their newborns | 3.5 | 35 | Citations (PDF) |
| 224 | Fab glycosylation of immunoglobulin G does not associate with improvement of rheumatoid arthritis during pregnancy | 4.2 | 34 | Citations (PDF) |
| 225 | LaCyTools: A Targeted Liquid Chromatography–Mass Spectrometry Data Processing Package for Relative Quantitation of Glycopeptides | 3.5 | 138 | Citations (PDF) |
| 226 | Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis | 12.4 | 186 | Citations (PDF) |
| 227 | Recent Advances in Clinical Glycoproteomics of Immunoglobulins (Igs) | 3.0 | 61 | Citations (PDF) |
| 228 | IgG and IgM glycosylation patterns in patients undergoing image-guided tumor ablation | 2.0 | 14 | Citations (PDF) |
| 229 | Acute phase inflammation is characterized by rapid changes in plasma/peritoneal fluid N-glycosylation in mice | 2.8 | 18 | Citations (PDF) |
| 230 | Histo-blood group glycans in the context of personalized medicine | 2.0 | 35 | Citations (PDF) |
| 231 | Site-specific O-Glycosylation Analysis of Human Blood Plasma Proteins | 3.0 | 74 | Citations (PDF) |
| 232 | The Art of Destruction: Optimizing Collision Energies in Quadrupole-Time of Flight (Q-TOF) Instruments for Glycopeptide-Based Glycoproteomics | 2.6 | 130 | Citations (PDF) |
| 233 | Regulation of autoantibody activity by the IL-23–TH17 axis determines the onset of autoimmune disease | 24.2 | 313 | Citations (PDF) |
| 234 | Reversed-phase separation methods for glycan analysis | 3.5 | 110 | Citations (PDF) |
| 235 | Patients with Autoimmune Anti-Red Blood Cell IgG1 Have Different Total- and Autoantibody -IgG1 Glycosylation Compared to Healthy Controls | 4.2 | 6 | Citations (PDF) |
| 236 | Two-Dimensional N-Glycan Distribution Mapping of Hepatocellular Carcinoma Tissues by MALDI-Imaging Mass Spectrometry | 4.4 | 104 | Citations (PDF) |
| 237 | Skewed Fc Glycosylation Profiles of Anti-proteinase 3 Immunoglobulin G1 Autoantibodies from Granulomatosis with Polyangiitis Patients Show Low Levels of Bisection, Galactosylation, and Sialylation | 3.5 | 54 | Citations (PDF) |
| 238 | Amino acid analysis using chromatography–mass spectrometry: An inter platform comparison study | 3.1 | 71 | Citations (PDF) |
| 239 | MassyTools: A High-Throughput Targeted Data Processing Tool for Relative Quantitation and Quality Control Developed for Glycomic and Glycoproteomic MALDI-MS | 3.5 | 117 | Citations (PDF) |
| 240 | Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid | 9.2 | 98 | Citations (PDF) |
| 241 | Prophylactic anti‐<scp>D</scp> preparations display variable decreases in <scp>F</scp>c‐fucosylation of anti‐<scp>D</scp> | 0.8 | 50 | Citations (PDF) |
| 242 | Mass spectrometry for glycosylation analysis of biopharmaceuticals | 11.2 | 72 | Citations (PDF) |
| 243 | Linkage-Specific Sialic Acid Derivatization for MALDI-TOF-MS Profiling of IgG Glycopeptides | 6.5 | 124 | Citations (PDF) |
| 244 | Hinge-Region O-Glycosylation of Human Immunoglobulin G3 (IgG3) | 3.0 | 109 | Citations (PDF) |
| 245 | Glycomic Analysis of Life Stages of the Human Parasite Schistosoma mansoni Reveals Developmental Expression Profiles of Functional and Antigenic Glycan Motifs* | 3.0 | 92 | Citations (PDF) |
| 246 | Glycoforms of Immunoglobulin G Based Biopharmaceuticals Are Differentially Cleaved by Trypsin Due to the Glycoform Influence on Higher-Order Structure | 3.5 | 37 | Citations (PDF) |
| 247 | Plasma N-Glycome Signature of Down Syndrome | 3.5 | 58 | Citations (PDF) |
| 248 | Site-Specific Protein N- and O-Glycosylation Analysis by a C18-Porous Graphitized Carbon–Liquid Chromatography-Electrospray Ionization Mass Spectrometry Approach Using Pronase Treated Glycopeptides | 6.5 | 81 | Citations (PDF) |
| 249 | Clinical Glycomics Employing Graphitized Carbon Liquid Chromatography–Mass Spectrometry | 1.2 | 82 | Citations (PDF) |
| 250 | Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis | 12.4 | 259 | Citations (PDF) |
| 251 | Human plasma protein N-glycosylation | 2.8 | 410 | Citations (PDF) |
| 252 | IgG Alloantibodies Against RBC Induced By Pregnancy or Transfusion Have Unique Glycosylation Patterns Which Correlate with Clinical Outcome of Hemolytic Disease of the Fetus or NewbornBlood, 2015, 126, 660-660 | 4.2 | 2 | Citations (PDF) |
| 253 | Comparison of Fc N-Glycosylation of Pharmaceutical Products of Intravenous Immunoglobulin G | 2.4 | 15 | Citations (PDF) |
| 254 | Alpha1-Antichymotrypsin Present in Therapeutic C1-Inhibitor Products Competes with Selectin - Sialyl LewisX InteractionBlood, 2015, 126, 1008-1008 | 4.2 | 0 | Citations (PDF) |
| 255 | Clinical Severity of Visceral Leishmaniasis Is Associated with Changes in Immunoglobulin G Fc N-Glycosylation | 4.4 | 48 | Citations (PDF) |
| 256 | Immunoglobulin G (IgG) Fab Glycosylation Analysis Using a New Mass Spectrometric High-throughput Profiling Method Reveals Pregnancy-associated Changes | 3.0 | 254 | Citations (PDF) |
| 257 | Comparative Performance of Four Methods for High-throughput Glycosylation Analysis of Immunoglobulin G in Genetic and Epidemiological Research | 3.0 | 191 | Citations (PDF) |
| 258 | Low anti‐<scp>R</scp>h<scp>D I</scp>g<scp>G</scp>‐<scp>F</scp>c‐fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn | 2.4 | 126 | Citations (PDF) |
| 259 | A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancyBlood, 2014, 123, 471-480 | 4.2 | 212 | Citations (PDF) |
| 260 | Improved nonreductive O-glycan release by hydrazinolysis with ethylenediaminetetraacetic acid addition | 2.4 | 40 | Citations (PDF) |
| 261 | Site-Specific N-Glycosylation Analysis of Human Immunoglobulin E | 3.5 | 101 | Citations (PDF) |
| 262 | Diagnostic serum glycosylation profile in patients with intellectual disability as a result of MAN1B1 deficiencyBrain, 2014, 137, 1030-1038 | 8.5 | 50 | Citations (PDF) |
| 263 | The role of glycosylation in IBD | 48.0 | 150 | Citations (PDF) |
| 264 | IgG Fc N-Glycosylation in Guillain–Barré Syndrome Treated with Immunoglobulins | 3.5 | 56 | Citations (PDF) |
| 265 | Total Plasma N-Glycome Changes during Pregnancy | 3.5 | 55 | Citations (PDF) |
| 266 | High-Throughput Profiling of Protein N-Glycosylation by MALDI-TOF-MS Employing Linkage-Specific Sialic Acid Esterification | 6.5 | 337 | Citations (PDF) |
| 267 | Inhibition of FcγR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcγRIIb in human macrophagesBlood, 2014, 124, 3709-3718 | 4.2 | 103 | Citations (PDF) |
| 268 | High-Throughput Analysis and Automation for Glycomics Studies | 1.2 | 88 | Citations (PDF) |
| 269 | High-Throughput IgG Fc N-Glycosylation Profiling by Mass Spectrometry of Glycopeptides | 3.5 | 209 | Citations (PDF) |
| 270 | High-throughput work flow for IgG Fc-glycosylation analysis of biotechnological samples | 2.4 | 62 | Citations (PDF) |
| 271 | Association between Galactosylation of Immunoglobulin G and Improvement of Rheumatoid Arthritis during Pregnancy Is Independent of Sialylation | 3.5 | 163 | Citations (PDF) |
| 272 | Coupling porous sheathless interface <scp>MS</scp> with transient‐<scp>ITP</scp> in neutral capillaries for improved sensitivity in glycopeptide analysis | 2.6 | 38 | Citations (PDF) |
| 273 | N-glycomic biomarkers of biological aging and longevity: A link with inflammaging | 12.0 | 215 | Citations (PDF) |
| 274 | Investigations on Aberrant Glycosylation of Glycosphingolipids in Colorectal Cancer Tissues Using Liquid Chromatography and Matrix-Assisted Laser Desorption Time-of-Flight Mass Spectrometry (MALDI-TOF-MS) | 3.0 | 59 | Citations (PDF) |
| 275 | Loci Associated with N-Glycosylation of Human Immunoglobulin G Show Pleiotropy with Autoimmune Diseases and Haematological Cancers | 3.3 | 355 | Citations (PDF) |
| 276 | Interlaboratory Study on Differential Analysis of Protein Glycosylation by Mass Spectrometry: The ABRF Glycoprotein Research Multi-Institutional Study 2012 | 3.0 | 105 | Citations (PDF) |
| 277 | Glycoproteomic Analysis of Antibodies | 3.0 | 155 | Citations (PDF) |
| 278 | Mapping <i><scp>O</scp></i>‐glycosylation of apolipoprotein <scp>C</scp>‐III in <scp>MALDI</scp>‐<scp>FT‐ICR</scp> protein profiles | 3.1 | 25 | Citations (PDF) |
| 279 | Structural Sampling of Glycan Interaction Profiles Reveals Mucosal Receptors for Fimbrial Adhesins of Enterotoxigenic Escherichia coli | 2.9 | 26 | Citations (PDF) |
| 280 | Targeted Biomarker Discovery by High Throughput Glycosylation Profiling of Human Plasma Alpha1-Antitrypsin and Immunoglobulin A | 2.4 | 47 | Citations (PDF) |
| 281 | N-glycosylation of Colorectal Cancer Tissues | 3.0 | 152 | Citations (PDF) |
| 282 | Changes in Antigen-specific IgG1 Fc N-glycosylation Upon Influenza and Tetanus Vaccination | 3.0 | 135 | Citations (PDF) |
| 283 | Highlight: Dolce vita – a sample from European glycobiology | 2.2 | 0 | Citations (PDF) |
| 284 | Glycoproteomic Analysis of Human Fibrinogen Reveals Novel Regions of O-Glycosylation | 3.5 | 44 | Citations (PDF) |
| 285 | Protein O-glycosylation analysis | 2.2 | 92 | Citations (PDF) |
| 286 | Fibrinogen alpha chain O-glycopeptides as possible markers of urinary tract infection | 2.4 | 34 | Citations (PDF) |
| 287 | Mass spectrometric O-glycan analysis after combined O-glycan release by beta-elimination and 1-phenyl-3-methyl-5-pyrazolone labeling | 2.0 | 67 | Citations (PDF) |
| 288 | Different fractions of human serum glycoproteins bind galectin-1 or galectin-8, and their ratio may provide a refined biomarker for pathophysiological conditions in cancer and inflammatory disease | 2.0 | 26 | Citations (PDF) |
| 289 | The major secreted protein Msp1/p75 is O-glycosylated in Lactobacillus rhamnosus GG | 4.6 | 78 | Citations (PDF) |
| 290 | MALDI‐TOF‐MS analysis of sialylated glycans and glycopeptides using 4‐chloro‐α‐cyanocinnamic acid matrix | 3.1 | 54 | Citations (PDF) |
| 291 | Alignment of laser‐induced fluorescence and mass spectrometric detection traces using electrophoretic mobility scaling in CE‐LIF‐MS of labeled <i>N</i>‐glycans | 2.6 | 20 | Citations (PDF) |
| 292 | Analysis of urinary oligosaccharides in lysosomal storage disorders by capillary high-performance anion-exchange chromatography–mass spectrometry | 3.5 | 32 | Citations (PDF) |
| 293 | Suppression of peeling during the release of O-glycans by hydrazinolysis | 2.4 | 65 | Citations (PDF) |
| 294 | Fc specific IgG glycosylation profiling by robust nano-reverse phase HPLC-MS using a sheath-flow ESI sprayer interface | 2.4 | 148 | Citations (PDF) |
| 295 | Hexapeptide library as a universal tool for sample preparation in protein glycosylation analysis | 2.4 | 21 | Citations (PDF) |
| 296 | Glycomics using mass spectrometry | 2.8 | 131 | Citations (PDF) |
| 297 | Comparison of the Fc glycosylation of fetal and maternal immunoglobulin G | 2.8 | 87 | Citations (PDF) |
| 298 | Skewing towards Decreased Fc-Fucosylation of Platelet-Alloantibodies in PregnancyBlood, 2012, 120, 3331-3331 | 4.2 | 1 | Citations (PDF) |
| 299 | High Throughput Isolation and Glycosylation Analysis of IgG–Variability and Heritability of the IgG Glycome in Three Isolated Human Populations | 3.0 | 506 | Citations (PDF) |
| 300 | Cotton HILIC SPE Microtips for Microscale Purification and Enrichment of Glycans and Glycopeptides | 6.5 | 351 | Citations (PDF) |
| 301 | Plasma protein N-glycan profiles are associated with calendar age, familial longevity and health | 3.5 | 97 | Citations (PDF) |
| 302 | Mannose-binding lectin does not explain the course and outcome of pregnancy in rheumatoid arthritis | 4.2 | 23 | Citations (PDF) |
| 303 | IgG Fc N<i>-</i>Glycosylation Changes in Lambert-Eaton Myasthenic Syndrome and Myasthenia Gravis | 3.5 | 95 | Citations (PDF) |
| 304 | Enrichment of Sialylated IgG by Lectin Fractionation Does Not Enhance the Efficacy of Immunoglobulin G in a Murine Model of Immune Thrombocytopenia | 2.4 | 107 | Citations (PDF) |
| 305 | Galectin-1-Binding Glycoforms of Haptoglobin with Altered Intracellular Trafficking, and Increase in Metastatic Breast Cancer Patients | 2.4 | 41 | Citations (PDF) |
| 306 | Mass spectrometric glycan rearrangements | 6.9 | 137 | Citations (PDF) |
| 307 | Recent advances in hydrophilic interaction liquid chromatography (HILIC) for structural glycomics | 2.6 | 183 | Citations (PDF) |
| 308 | Polymorphisms in B3GAT1, SLC9A9 and MGAT5 are associated with variation within the human plasma N-glycome of 3533 European adults | 3.0 | 87 | Citations (PDF) |
| 309 | Glycan labeling strategies and their use in identification and quantification | 3.5 | 456 | Citations (PDF) |
| 310 | Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function | 2.3 | 71 | Citations (PDF) |
| 311 | Glycan profiling of anti–citrullinated protein antibodies isolated from human serum and synovial fluid | 6.0 | 200 | Citations (PDF) |
| 312 | Protein glycosylation analysis by HILIC‐LC‐MS of Proteinase K‐generated <i>N</i>‐ and <i>O</i>‐glycopeptides | 2.9 | 101 | Citations (PDF) |
| 313 | Ligand identification of carbohydrate-binding proteins employing a biotinylated glycan binding assay and tandem mass spectrometry | 2.4 | 9 | Citations (PDF) |
| 314 | 2‐Picoline‐borane: A non‐toxic reducing agent for oligosaccharide labeling by reductive amination | 3.1 | 176 | Citations (PDF) |
| 315 | Glycan profiling of urine, amniotic fluid and ascitic fluid from galactosialidosis patients reveals novel oligosaccharides with reducing end hexose and aldohexonic acid residues | 5.5 | 14 | Citations (PDF) |
| 316 | Decreased Levels of Bisecting GlcNAc Glycoforms of IgG Are Associated with Human Longevity | 2.4 | 115 | Citations (PDF) |
| 317 | Mass Spectrometric Identification of Aberrantly Glycosylated Human Apolipoprotein C-III Peptides in Urine from Schistosoma mansoni-infected Individuals | 3.0 | 36 | Citations (PDF) |
| 318 | Structural Characterization of Glycans on Omega-1, a Major <i>Schistosoma mansoni</i> Egg Glycoprotein That Drives Th2 Responses | 3.5 | 51 | Citations (PDF) |
| 319 | Immunoglobulin G Glycopeptide Profiling by Matrix-Assisted Laser Desorption Ionization Fourier Transform Ion Cyclotron Resonance Mass Spectrometry | 6.5 | 110 | Citations (PDF) |
| 320 | Optimized Workflow for Preparation of APTS-Labeled N-Glycans Allowing High-Throughput Analysis of Human Plasma Glycomes using 48-Channel Multiplexed CGE-LIF | 3.5 | 151 | Citations (PDF) |
| 321 | Natural glycan microarrays | 2.1 | 29 | Citations (PDF) |
| 322 | Golgi targeting of Drosophila melanogaster β4GalNAcTB requires a DHHC protein family–related protein as a pilot | 5.5 | 20 | Citations (PDF) |
| 323 | Molecular characterisation of kappa-5, a major antigenic glycoprotein from Schistosoma mansoni eggs | 1.3 | 61 | Citations (PDF) |
| 324 | Structural glycomics using hydrophilic interaction chromatography (HILIC) with mass spectrometry | 6.9 | 240 | Citations (PDF) |
| 325 | Oligosaccharide analysis by graphitized carbon liquid chromatography–mass spectrometry | 3.5 | 183 | Citations (PDF) |
| 326 | IgG glycosylation analysis | 3.1 | 307 | Citations (PDF) |
| 327 | Immunoglobulin 1 (IgG1) Fc‐glycosylation profiling of anti‐citrullinated peptide antibodies from human serum | 2.3 | 36 | Citations (PDF) |
| 328 | Hexose Rearrangements upon Fragmentation of <i>N</i>-Glycopeptides and Reductively Aminated <i>N</i>-Glycans | 6.5 | 43 | Citations (PDF) |
| 329 | Regulated Glycosylation Patterns of IgG during Alloimmune Responses against Human Platelet Antigens | 3.5 | 116 | Citations (PDF) |
| 330 | Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study | 4.2 | 255 | Citations (PDF) |
| 331 | Relevance and use of capillary coatings in capillary electrophoresis–mass spectrometry | 3.5 | 179 | Citations (PDF) |
| 332 | Serum antibody screening by surface plasmon resonance using a natural glycan microarray | 2.8 | 93 | Citations (PDF) |
| 333 | Glycomics of bone marrow-derived mesenchymal stem cells can be used to evaluate their cellular differentiation stage | 2.8 | 64 | Citations (PDF) |
| 334 | Efficient introduction of a bisecting GlcNAc residue in tobacco N-glycans by expression of the gene encoding human N-acetylglucosaminyltransferase III | 2.2 | 65 | Citations (PDF) |
| 335 | General Microarray Technique for Immobilization and Screening of Natural Glycans | 6.5 | 92 | Citations (PDF) |
| 336 | Glycoproteomics based on tandem mass spectrometry of glycopeptides | 2.6 | 390 | Citations (PDF) |
| 337 | Electron transfer dissociation ofN-glycopeptides: loss of the entireN-glycosylated asparagine side chain | 1.5 | 95 | Citations (PDF) |
| 338 | Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum | 3.1 | 273 | Citations (PDF) |
| 339 | Glycomics-driven discoveries in schistosome research | 1.4 | 88 | Citations (PDF) |
| 340 | Targeted identification of a unique glycan epitope of Schistosoma mansoni egg antigens using a diagnostic antibody | 1.3 | 37 | Citations (PDF) |
| 341 | Distinct contributions of β4GalNAcTA and β4GalNAcTB to Drosophila glycosphingolipid biosynthesis | 2.8 | 24 | Citations (PDF) |
| 342 | Matrix-assisted laser desorption/ionization in-source decay combined with tandem time-of-flight mass spectrometry of permethylated oligosaccharides: targeted characterization of specific parts of the glycan structure | 1.5 | 26 | Citations (PDF) |
| 343 | Mass spectrometry of proton adducts of fucosylated N-glycans: fucose transfer between antennae gives rise to misleading fragments | 1.5 | 148 | Citations (PDF) |
| 344 | Repeats of LacdiNAc and fucosylated LacdiNAc on N‐glycans of the human parasite <i>Schistosoma mansoni</i> | 5.5 | 69 | Citations (PDF) |
| 345 | IPSE/alpha-1, a major secretory glycoprotein antigen from schistosome eggs, expresses the Lewis X motif on core-difucosylated N-glycans | 5.5 | 84 | Citations (PDF) |
| 346 | Gender-specific expression of complex-type N-glycans in schistosomes | 2.2 | 56 | Citations (PDF) |
| 347 | Receptor binding studies disclose a novel class of high‐affinity inhibitors of the <i>Escherichia coli</i> FimH adhesin | 2.6 | 414 | Citations (PDF) |
| 348 | Protein glycosylation analysis by liquid chromatography–mass spectrometry | 2.6 | 194 | Citations (PDF) |
| 349 | Oligosaccharide analysis by capillary-scale high-pH anion-exchange chromatography with on-line ion-trap mass spectrometry | 2.6 | 69 | Citations (PDF) |
| 350 | Molecular characterization of omega-1: A hepatotoxic ribonuclease from Schistosoma mansoni eggs | 1.3 | 92 | Citations (PDF) |
| 351 | Identification and Characterization of Keyhole Limpet Hemocyanin N-Glycans Mediating Cross-reactivity with Schistosoma mansoni | 2.2 | 89 | Citations (PDF) |
| 352 | Mapping fucosylated epitopes on glycoproteins and glycolipids ofSchistosoma mansonicercariae, adult worms and eggs | 1.8 | 62 | Citations (PDF) |
| 353 | Negative-Mode MALDI-TOF/TOF-MS of Oligosaccharides Labeled with 2-Aminobenzamide | 6.5 | 53 | Citations (PDF) |
| 354 | Protein Glycosylation Analyzed by Normal-Phase Nano-Liquid Chromatography−Mass Spectrometry of Glycopeptides | 6.5 | 130 | Citations (PDF) |
| 355 | New features of site-specific horseradish peroxidase (HRP) glycosylation uncovered by nano-LC-MS with repeated ion-isolation/fragmentation cycles | 2.0 | 51 | Citations (PDF) |
| 356 | Glycopeptide analysis by matrix-assisted laser desorption/ionization tandem time-of-flight mass spectrometry reveals novel features of horseradish peroxidase glycosylation | 1.5 | 86 | Citations (PDF) |
| 357 | Characterization of keyhole limpet hemocyanin (KLH) glycans sharing a carbohydrate epitope with Schistosoma mansoni glycoconjugates | 2.3 | 23 | Citations (PDF) |
| 358 | Nano-scale liquid chromatography-mass spectrometry of 2-aminobenzamide-labeled oligosaccharides at low femtomole sensitivity | 1.6 | 50 | Citations (PDF) |
| 359 | Normal-Phase Nanoscale Liquid Chromatography−Mass Spectrometry of Underivatized Oligosaccharides at Low-Femtomole Sensitivity | 6.5 | 120 | Citations (PDF) |
| 360 | A novel Gal(beta1-4)Gal(beta1-4)Fuc(alpha1-6)-core modification attached to the proximal N-acetylglucosamine of keyhole limpet haemocyanin (KLH) N-glycans | 3.9 | 76 | Citations (PDF) |
| 361 | Localization of defined carbohydrate epitopes in bovine polysialylated NCAM | 2.9 | 42 | Citations (PDF) |
| 362 | The parasitic trematode Fasciola hepatica exhibits mammalian-type glycolipids as well as Gal( 1-6)Gal-terminating glycolipids that account for cestode serological cross-reactivity | 2.2 | 46 | Citations (PDF) |
| 363 | A novel GlcNAcalpha1-HPO3-6Gal(1-1)ceramide antigen and alkylated inositol-phosphoglycerolipids expressed by the liver fluke Fasciola hepatica | 2.2 | 27 | Citations (PDF) |
| 364 | Localization and characterization of polysialic acid-containing N-linked glycans from bovine NCAM | 2.2 | 62 | Citations (PDF) |
| 365 | SCHISTOSOMA MANSONI AND SCHISTOSOMA HAEMATOBIUM: IDENTIFICATION AND CHARACTERIZATION OF GLYCOCONJUGATE ANTIGENS IN THE HEMOLYMPH OF INFECTED VECTOR SNAILS | 0.8 | 13 | Citations (PDF) |
| 366 | Schistosoma mansoni and Schistosoma haematobium: Identification and Characterization of Glycoconjugate Antigens in the Hemolymph of Infected Vector Snails | 0.8 | 0 | Citations (PDF) |
| 367 | Fuc(α1→3)GalNAc-: the major antigenic motif of Schistosoma mansoni glycolipids implicated in infection sera and keyhole-limpet haemocyanin cross-reactivity | 3.9 | 52 | Citations (PDF) |
| 368 | Bovine lymphocytes express functional receptors for Escherichia coli Shiga toxin 1 | 3.3 | 21 | Citations (PDF) |
| 369 | Characterization of glycosphingolipids fromSchistosoma mansonieggs carrying Fuc(α1-3)GalNAc-, GalNAc(β1-4)[Fuc(α1-3)]GlcNAc- and Gal(β1-4)[Fuc(α1-3)]GlcNAc- (Lewis X) terminal structures | 0.2 | 62 | Citations (PDF) |
| 370 | Hemocyanin from the keyhole limpet Megathura crenulata
(KLH) carries a novel type of N-glycans with Gal(β1-6)Man-motifs | 0.2 | 77 | Citations (PDF) |
| 371 | Globotriaosylceramide (Gb3/CD77) is synthesized and surface expressed by bovine lymphocytes upon activation in vitro | 1.3 | 23 | Citations (PDF) |
| 372 | The Liver Flukes Fasciola gigantica and Fasciola hepatica Express the Leucocyte Cluster of Differentiation Marker CD77 (Globotriaosylceramide) in Their Tegument | 2.2 | 21 | Citations (PDF) |
| 373 | Local Variability of the Phosphoglycerate Kinase-Triosephosphate Isomerase Fusion Protein from Thermotoga maritima MSB 8 | 2.2 | 3 | Citations (PDF) |
| 374 | Phosphocholine-containing, zwitterionic glycosphingolipids of adult Onchocerca volvulus as highly conserved antigenic structures of parasitic nematodes | 3.9 | 20 | Citations (PDF) |
| 375 | Phosphocholine-containing, zwitterionic glycosphingolipids of adult Onchocerca volvulus as highly conserved antigenic structures of parasitic nematodes | 3.9 | 57 | Citations (PDF) |
| 376 | A fucose-containing epitope is shared by keyhole limpet haemocyanin and Schistosoma mansoni glycosphingolipids | 1.3 | 28 | Citations (PDF) |
| 377 | Schistosoma mansoni cercarial glycolipids are dominated by Lewis X and pseudo-Lewis Y structures | 2.2 | 82 | Citations (PDF) |
| 378 | Stage-associated expression of ceramide structures in glycosphingolipids from the human trematode parasite Schistosoma mansoni | 2.0 | 20 | Citations (PDF) |
| 379 | Immunochemical characterisation of Schistosoma mansoni glycolipid antigens | 1.3 | 35 | Citations (PDF) |
| 380 | Structural Analysis of Glycoconjugates by On-Target Enzymatic Digestion and MALDI-TOF-MS | 6.5 | 77 | Citations (PDF) |
| 381 | ACPA IgG galactosylation associates with disease activity in pregnant patients with rheumatoid arthritis | 12.4 | 38 | Citations (PDF) |
